Shriram Finance Stock On Fire: 150% Dividend Announced, Don’t Miss Record Date; Key Levels To Watch

Shriram Finance's stock wrapped up Monday at Rs 621.60 a share, down 5.13%, with a market value of Rs 1.17LCr. Following the release of its Q4 FY25 earnings, which fell short of market expectations, the stock has been on a slide. SFL reported in-line 4Q PAT, although NIM was muted in addition to the company's modest AUM growth and excessive provisioning. Additionally, the company announced its FY25 final dividend. Here is a brief discussion of the record date, Q4 earnings, and key levels to keep an eye on for the stock.

Shriram Finance Dividend

"The Board of Directors in its meeting held today recommended a Final Dividend of Rs.3/- per share of face value of Rs.2/- each fully paid-up (i.e.150%) for the Financial Year ended March 31, 2025 and pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Record Date for payment of Final Dividend will be Friday, July 11, 2025 subject to approval of Members at the ensuing 46th Annual General Meeting (AGM). The Final Dividend payout will be made to eligible Members on or before Saturday, August 16, 2025," said Shriram Finance in a stock exchange filing.

"This is in addition to the interim dividend of Rs. 22/- per equity share (pre-split) of Rs. 10/- each and second interim dividend Rs. 2.50 per equity share of Rs. 2/- each (post-split) fully paid-up for the financial year 2024-25 declared by the Company on October 25, 2024 and January 24, 2025 respectively. With this the total dividend for the financial year 2024-25 will be Rs. 9.90 per share of Rs. 2/- each after adjusting for split. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and subject to the confirmation by the Stock Exchanges, the book closure period for the purpose of payment of the final dividend and 46th AGM will be from July 12, 2025 to July 18, 2025 (both days inclusive). The final dividend will be paid to eligible Members on or before August 16, 2025 subject to deduction of tax at source as per the applicable rate(s) to the eligible shareholders," said Shriram Finance in a statement.

Shriram Finance Q4 Results

In Q4FY25, Shriram Finance recorded a standalone net profit of Rs 2,139 crore, up 10% year-on-year (YoY) from Q4FY24's Rs 194.59 crore. While NIM decreased 77 basis points YoY to 8.25 per cent in Q4FY25 from 9.02 per cent in Q4FY24, the company's net interest income (NII) climbed 13.4 percent YoY to Rs. 6,051.19 Cr. The quarter's total income was Rs 11,460.25 crore, up from Rs 9,497.85 crore in Q4 of FY24. The basic earnings per share (EPS) grew by 9.85% to Rs. 11.38 from Rs. 10.36 during the same period last year.

Compared to the year ended March 31, 2024, when it was Rs. 19,686.85 crores, the Net Interest Income for the year ended March 31, 2025, was Rs. 22,835.09 crores, a 15.99% growth. In FY25, the net profit was Rs. 9,761.00 crores, compared to Rs. 7,190.48 crores in the same period the year before. As of March 31, 2025, the total assets under management were at Rs. 2,63,190.27 crores, up 17.05 percent from Rs. 2,24,861.98 crores on March 31, 2024, and Rs. 2,54,469.69 crores on December 31, 2024.

Shriram Finance Share Price Target

"The stock is trading in a positive trend with support at Rs 610 and resistance at Rs 640. The RSI is in bullish territory, indicating strong momentum, and the MACD has recently crossed above its signal line. A breakout above Rs 640 could drive the stock higher towards Rs 650-660, maintaining the uptrend," commented Riyank Arora - Technical Analyst - Mehta Equities Limited.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor Greynium Information Technologies. The author, nor the brokerage firm nor Greynium would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.